Understanding tensions and identifying clinician agreement on improvements to early-stage chronic kidney disease monitoring in primary care: a qualitative study

Rosemary Simmonds, Julie Evans, Gene Feder, Tom Blakeman, Dan Lasserson, Elizabeth Murray, Kristina Bennert, Louise Locock, Jeremy Horwood

Research output: Contribution to journalArticle

5 Citations (Scopus)
4 Downloads (Pure)

Abstract

Since 2006, general practitioners (GPs) in England, UK, have been incentivised to keep a register and monitor patients with chronic kidney disease (CKD) stages 3-5. Despite tensions and debate around the merit of this activity, there has been little qualitative research exploring clinician perspectives on monitoring early-stage CKD in primary care. This study aimed to examine and understand a range of different healthcare professional views and experiences of identification and monitoring in primary care of early-stage CKD, in particular stage 3.Qualitative design using semistructured interviews.National Health Service (NHS) settings across primary and secondary care in South West England, UK.25 clinicians: 16 GPs, 3 practice nurses, 4 renal consultants and 2 public health physicians.We identified two related overarching themes of dissonance and consonance in clinician perspectives on early-stage CKD monitoring in primary care. Clinician dissonance around clinical guidelines for CKD monitoring emanated from different interpretations of CKD and different philosophies of healthcare and moral decision-making. Clinician consonance centred on the need for greater understanding of renal decline and increasing proteinuria testing to reduce overdiagnosis and identify those patients who were at risk of progression and further morbidity and who would benefit from early intervention. Clinicians recommended adopting a holistic approach for patients with CKD representing a barometer of overall health.The introduction of new National Institute for Health and Care Excellence (NICE) CKD guidelines in 2014, which focus the meaning and purpose of CKD monitoring by increased proteinuria testing and assessment of risk, may help to resolve some of the ethical and moral tensions clinicians expressed regarding the overmedicalisation of patients with a CKD diagnosis.
Original languageEnglish
Article numbere010337
JournalBMJ Open
Volume6
Issue number3
DOIs
Publication statusPublished - 1 Mar 2016

Fingerprint

Chronic Renal Insufficiency
Primary Health Care
Delivery of Health Care
Proteinuria
England
General Practitioners
Guidelines
Kidney
Secondary Care
Qualitative Research
National Institutes of Health (U.S.)
National Health Programs
Consultants
Decision Making
Public Health
Nurses
Interviews
Morbidity
Physicians
Health

Cite this

Understanding tensions and identifying clinician agreement on improvements to early-stage chronic kidney disease monitoring in primary care : a qualitative study. / Simmonds, Rosemary; Evans, Julie; Feder, Gene; Blakeman, Tom; Lasserson, Dan; Murray, Elizabeth; Bennert, Kristina ; Locock, Louise; Horwood, Jeremy.

In: BMJ Open, Vol. 6, No. 3, e010337, 01.03.2016.

Research output: Contribution to journalArticle

Simmonds, Rosemary ; Evans, Julie ; Feder, Gene ; Blakeman, Tom ; Lasserson, Dan ; Murray, Elizabeth ; Bennert, Kristina ; Locock, Louise ; Horwood, Jeremy. / Understanding tensions and identifying clinician agreement on improvements to early-stage chronic kidney disease monitoring in primary care : a qualitative study. In: BMJ Open. 2016 ; Vol. 6, No. 3.
@article{d4271b1425924d91a8759ae17a2106ca,
title = "Understanding tensions and identifying clinician agreement on improvements to early-stage chronic kidney disease monitoring in primary care: a qualitative study",
abstract = "Since 2006, general practitioners (GPs) in England, UK, have been incentivised to keep a register and monitor patients with chronic kidney disease (CKD) stages 3-5. Despite tensions and debate around the merit of this activity, there has been little qualitative research exploring clinician perspectives on monitoring early-stage CKD in primary care. This study aimed to examine and understand a range of different healthcare professional views and experiences of identification and monitoring in primary care of early-stage CKD, in particular stage 3.Qualitative design using semistructured interviews.National Health Service (NHS) settings across primary and secondary care in South West England, UK.25 clinicians: 16 GPs, 3 practice nurses, 4 renal consultants and 2 public health physicians.We identified two related overarching themes of dissonance and consonance in clinician perspectives on early-stage CKD monitoring in primary care. Clinician dissonance around clinical guidelines for CKD monitoring emanated from different interpretations of CKD and different philosophies of healthcare and moral decision-making. Clinician consonance centred on the need for greater understanding of renal decline and increasing proteinuria testing to reduce overdiagnosis and identify those patients who were at risk of progression and further morbidity and who would benefit from early intervention. Clinicians recommended adopting a holistic approach for patients with CKD representing a barometer of overall health.The introduction of new National Institute for Health and Care Excellence (NICE) CKD guidelines in 2014, which focus the meaning and purpose of CKD monitoring by increased proteinuria testing and assessment of risk, may help to resolve some of the ethical and moral tensions clinicians expressed regarding the overmedicalisation of patients with a CKD diagnosis.",
author = "Rosemary Simmonds and Julie Evans and Gene Feder and Tom Blakeman and Dan Lasserson and Elizabeth Murray and Kristina Bennert and Louise Locock and Jeremy Horwood",
note = "Funding This article presents independent research funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR) (reference:120). JE was also supported by the NIHR Programme Grants for Applied Research programme (Reference: RP-PG-1210-12012). DSL and LL are supported by the NIHR Oxford Biomedical Research Centre",
year = "2016",
month = "3",
day = "1",
doi = "10.1136/bmjopen-2015-010337",
language = "English",
volume = "6",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "3",

}

TY - JOUR

T1 - Understanding tensions and identifying clinician agreement on improvements to early-stage chronic kidney disease monitoring in primary care

T2 - a qualitative study

AU - Simmonds, Rosemary

AU - Evans, Julie

AU - Feder, Gene

AU - Blakeman, Tom

AU - Lasserson, Dan

AU - Murray, Elizabeth

AU - Bennert, Kristina

AU - Locock, Louise

AU - Horwood, Jeremy

N1 - Funding This article presents independent research funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR) (reference:120). JE was also supported by the NIHR Programme Grants for Applied Research programme (Reference: RP-PG-1210-12012). DSL and LL are supported by the NIHR Oxford Biomedical Research Centre

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Since 2006, general practitioners (GPs) in England, UK, have been incentivised to keep a register and monitor patients with chronic kidney disease (CKD) stages 3-5. Despite tensions and debate around the merit of this activity, there has been little qualitative research exploring clinician perspectives on monitoring early-stage CKD in primary care. This study aimed to examine and understand a range of different healthcare professional views and experiences of identification and monitoring in primary care of early-stage CKD, in particular stage 3.Qualitative design using semistructured interviews.National Health Service (NHS) settings across primary and secondary care in South West England, UK.25 clinicians: 16 GPs, 3 practice nurses, 4 renal consultants and 2 public health physicians.We identified two related overarching themes of dissonance and consonance in clinician perspectives on early-stage CKD monitoring in primary care. Clinician dissonance around clinical guidelines for CKD monitoring emanated from different interpretations of CKD and different philosophies of healthcare and moral decision-making. Clinician consonance centred on the need for greater understanding of renal decline and increasing proteinuria testing to reduce overdiagnosis and identify those patients who were at risk of progression and further morbidity and who would benefit from early intervention. Clinicians recommended adopting a holistic approach for patients with CKD representing a barometer of overall health.The introduction of new National Institute for Health and Care Excellence (NICE) CKD guidelines in 2014, which focus the meaning and purpose of CKD monitoring by increased proteinuria testing and assessment of risk, may help to resolve some of the ethical and moral tensions clinicians expressed regarding the overmedicalisation of patients with a CKD diagnosis.

AB - Since 2006, general practitioners (GPs) in England, UK, have been incentivised to keep a register and monitor patients with chronic kidney disease (CKD) stages 3-5. Despite tensions and debate around the merit of this activity, there has been little qualitative research exploring clinician perspectives on monitoring early-stage CKD in primary care. This study aimed to examine and understand a range of different healthcare professional views and experiences of identification and monitoring in primary care of early-stage CKD, in particular stage 3.Qualitative design using semistructured interviews.National Health Service (NHS) settings across primary and secondary care in South West England, UK.25 clinicians: 16 GPs, 3 practice nurses, 4 renal consultants and 2 public health physicians.We identified two related overarching themes of dissonance and consonance in clinician perspectives on early-stage CKD monitoring in primary care. Clinician dissonance around clinical guidelines for CKD monitoring emanated from different interpretations of CKD and different philosophies of healthcare and moral decision-making. Clinician consonance centred on the need for greater understanding of renal decline and increasing proteinuria testing to reduce overdiagnosis and identify those patients who were at risk of progression and further morbidity and who would benefit from early intervention. Clinicians recommended adopting a holistic approach for patients with CKD representing a barometer of overall health.The introduction of new National Institute for Health and Care Excellence (NICE) CKD guidelines in 2014, which focus the meaning and purpose of CKD monitoring by increased proteinuria testing and assessment of risk, may help to resolve some of the ethical and moral tensions clinicians expressed regarding the overmedicalisation of patients with a CKD diagnosis.

U2 - 10.1136/bmjopen-2015-010337

DO - 10.1136/bmjopen-2015-010337

M3 - Article

VL - 6

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 3

M1 - e010337

ER -